Phthalates are plasticizers with widespread industrial, domestic, and medical applications. Epidemiological data indicating increased incidence of testicular dysgenesis in boys exposed to phthalates in utero are reinforced by studies demonstrating that phthalates impair fetal rodent testis development. Because humans are exposed to phthalates continuously from gestation through adulthood, it is imperative to understand what threat phthalates pose at other life stages. To determine the impact during prepuberty, we assessed the consequences of oral administration of 1 to 500 mg di-n-butyl phthalate (DBP)/kg/d in corn oil to wild-type (C57BL/6J) male mice from 4 to 14 days of age. Dose-dependent effects on testis growth correlated with reduced Sertoli cell proliferation. Histological and immunohistochemical analyses identified delayed spermatogenesis and impaired Sertoli cell maturation after exposure to 10 to 500 mg DBP/kg/d. Interference with the hypothalamic-pituitary-gonadal axis was indicated in mice fed 500 mg DBP/kg/d, which had elevated circulating inhibin but no change in serum FSH. Increased immunohistochemical staining for inhibin-␣ was apparent at doses of 10 to 500 mg DBP/kg/d. Serum testosterone and testicular androgen activity were lower in the 500 mg DBP/kg/d group; however, reduced anogenital distance in all DBP-treated mice suggested impaired androgen action at earlier time points. Long-term effects were evident, with smaller anogenital distance and indications of disrupted spermatogenesis in adult mice exposed prepubertally to doses from 1 mg DBP/kg/d. These data demonstrate the acute sensitivity of the prepubertal mouse testis to DBP at doses 50-to 500-fold lower than those used in rat and identify the upregulation of inhibin as a potential mechanism of DBP action. (Endocrinology 154: 3460 -3475, 2013) P hthalate diesters (phthalates) are chemicals that are broadly used in the manufacture of plastics, solvents, sealants, paints, varnishes, and personal care products as well as in the food processing, medical, and pharmaceutical industries (reviewed in Refs. 1 and 2). Human exposure occurs by ingestion, absorption, and inhalation, and all studies published to date have confirmed the presence of phthalate metabolites in human urine as well as some serum and breast milk samples, demonstrating the ubiquitous and unavoidable nature of these chemicals (2-5). Concern about the effect of phthalates on human health has been sustained because of the indicated link between phthalate exposure and disorders of male reproductive development, which include hypospadias, cryptorchidism and the presence of multinucleated germ cells (6, 7), and adult pathologies such as Leydig cell aggregation (8 -10),
Sertoli cell-only tubules, poor spermatogenesis (8) , testicular germ cell tumors, and reduced semen quality. Reports that the incidence of these conditions has risen over the last several decades are fueling investigations into whether phthalate exposure is a concern with regard to male reproductive health (11) (12) (13) (14) (15) .
Although epidemiological studies and biomonitoring of exposed human populations have indicated positive correlations of phthalate exposure and reproductive abnormalities in males (1, 15) , it is well recognized that drawing conclusive links between phthalates and testicular dysgenesis syndrome is difficult due to the complications of lifestyle factors, human genetic variability, and the typically small population sizes examined (16, 17) . Whereas extrapolations based on biomonitoring outcomes indicate most people have exposure below the no observable adverse effect level defined in rodent studies, some individuals do have urinary metabolite levels indicative of exposure that exceeds the tolerable daily intake (18 -20) . This includes patients hospitalized under intensive care and individuals receiving blood transfusions or enteric-coated medications, in whom metabolites have been measured at several thousand-fold higher levels than the general population (21) (22) (23) (24) (25) . It is therefore imperative to understand the risks posed by this high phthalate exposure.
Progress in understanding the impact of phthalates on human health has also been hampered because of the lack of a suitable animal model and the inability to reproduce in vivo effects using in vitro techniques. Much of what we know about phthalate effects on the testis has been gleaned from studies using rats administered very high doses of di-n-butyl phthalate (DBP) or di-ethylhexyl phthalate, typically 100 or 500 mg/kg body weight. Existing data indicate the rat testis is most sensitive during fetal life, with several features of human testicular dysgenesis syndrome observed in exposed rats (6, 11, 12, 14, 26 -32) . Postnatal outcomes from fetal phthalate exposure range from no observed effect to germ cell loss, delayed pubertal development, and disruption of Sertoli cell junctions (33) (34) (35) . Recent findings, however, have demonstrated that the response of the human fetal testis to phthalate exposure is most similar to that of the mouse (30) , not rat, strongly indicating that the mouse is a better model for understanding phthalate effects in humans.
Many studies have demonstrated that urinary levels of phthalate metabolites in children are higher than in adults (reviewed in Ref. 2 ), yet few have examined the effect of phthalates on prepubertal development. The objective of the present study was to evaluate the mouse as an experimental model for phthalate effects on human prepubertal testis development. We developed a regime of oral administration of DBP during the neonatal to prepubertal period, to reflect exposure to a phthalate that is consistently detected in humans and that is understood to be the phthalate species to which children have greatest exposure (3) . Our data demonstrate the susceptibility and sensitivity of the male prepubertal mouse to DBP doses that are much lower than those used in rat studies and identify distinct effects on somatic and germ cells as well as indicators of a perturbed endocrine profile. These findings have identified a potential mechanism by which phthalates impair testis development and define the timing of critical physiological events during prepubertal life that are vulnerable to phthalates exposure, with outcomes suggesting longterm impacts on adult reproductive health and well-being. Importantly, that doses as low as 1 and 10 mg DBP/kg body weight per day are detrimental is relevant to boys with health conditions requiring medical care that involves chronic exposure to much higher phthalate levels than in the general population.
Materials and Methods

Experimental animals
Wild-type C57BL/6J mice (Monash University Central Animal Services, Clayton, Victoria, Australia) were housed at Animal Research Laboratories (Monash University). Investigations conformed to the National Health and Medical Research Council/Commonwealth Scientific and Industrial Research Organisation/Australian Agricultural Council Code of Practice for the Care and Use of Animals for Experimental Purposes and were approved by the Monash University Standing Committee on Ethics in Animal Experimentation. When pregnancy was determined, males were removed and dams monitored daily until day of birth, designated day 0. Mice were maintained on a soy-free diet (AIM93M; Specialty Feeds, Perth, Australia) ad libitum and housed in an environment of a 12-hour light, 12-hour dark cycle at 18°C to 24°C with 40% to 70% humidity.
Corn oil (Sigma-Aldrich, St Louis, Missouri) or DBP (Chem Service, West Chester, Pennsylvania) dissolved in corn oil was fed to male pups via pipette between 8:00 am and noon daily from 4 days postpartum (dpp) until day 7, 14, or 21. DBP dose ranged from 1 to 500 mg/kg body weight per day, prepared such that the volume delivered was 1 l/g body weight. Litters were randomly assigned to treatments, and litter size ranged between 5 and 10. Mouse pups that failed to gain weight were killed as stipulated in animal ethics. Juvenile mice were killed by decapitation after 3 or 10 days treatment. Trunk blood was collected into a Microvette tube (Sarstedt, Technology Park, Australia) and placed at 20°C overnight. Serum was separated by centrifugation at 16 162 g for 90 seconds at room temperature and then transferred to an Eppendorf tube and recentrifuged. Serum was collected and stored at Ϫ80°C. For the adult study, mice were treated until day 21, then maintained without further DBP administration until 8 weeks of age, and then killed by cervical dislocation. Testis, spleen, kidney, liver, and heart weights were recorded. One testis was fixed in Bouin's fixative for 5 hours, dehydrated through a graded ethanol series, embedded in paraffin, and sectioned at ϳ4 m onto Superfrost Plus II slides (Lomb Scientific, Sydney, Australia). The second testis was snapfrozen and stored at Ϫ80°C for gene expression analyses.
Anogenital distance (AGD) was imaged by photographing the anogenital area immediately after killing using a Leica microscope (MZ FLIII; Leica, Mt Waverly, Australia) and camera (DFC300 FX; Leica), with mice mounted on a transparent plastic tray at a fixed distance from the camera. The distance between the center of the anus and the base of the genital tubercle was measured in pixels (ImageJ software; National Institute of Health, Bethesda, Maryland) and converted to millimeters using a ruler photographed under identical conditions.
Serum hormone RIAs
Detailed descriptions of the FSH and inhibin RIA specificity, accuracy, precision, sensitivity, parallelism, recovery, and quality controls are described in Supplemental Figure 1 (published on The Endocrine Society's Journals Online web site at http://endo.endojournals.org). Briefly, FSH was measured in sera from individual animals in 20-l duplicates (7 dpp, single assay) or 10-l duplicates (14 dpp, 2 assays) using rabbit antisera S-11 supplied by Dr Parlow, National Institute of Diabetes and Digestive and Kidney Diseases (Bethesda, Maryland) and goat antirabbit IgG (GAR12). Intra-assay coefficients of variation were 3.7% and 3.6%, and lowest levels of detection were 0.93 and 1.57 ng/mL. Inhibin was assayed in individual animals using 20-l duplicates (36) with rabbit antisera (no. 1989; Monash Institute of Medical Research, Monash University) and goat antirabbit IgG (GAR12; Monash Institute of Medical Research) with 9.1% intra-assay coefficient of variation and lower limit of detection of 0.24 ng/mL. Testosterone was measured in 25-l duplicates (IM1119; Immunotech, Marseille, France) with an intra-assay coefficient of variation of 5.6% and lower limit of detection of 39.59 pg/mL.
Immunohistochemistry/immunofluorescence
Section immunohistochemistry/fluorescence was performed as described (37) . Antibodies used were cleaved caspase 3 (1:200 dilution; Abcam, Cambridge, United Kingdom), proliferating cell nuclear antigen (PCNA) (0.96 ng/mL; Dako, Carpinteria, California), SRY (sex determining region Y)-box 9 (SOX9) (2 g/mL; Santa Cruz Biotechnology, Santa Cruz, California), antiMüllerian hormone (AMH) (0.4 g/mL; Santa Cruz), androgen receptor (AR) (0.2 g/mL; Santa Cruz), connexin 43 (Cx43, 1:600, Abcam, Cambridge, United Kingdom), inhibin ␣-subunit (13.5 g/mL; gift from Associate Professor David Robertson, Prince Henry's Institute, Clayton, Victoria, Australia), and germ cell nuclear antigen (GCNA) (10D9G11; gift from George Enders, University of Kansas; 1:100 dilution). For immunohistochemistry, bound primary antibodies were detected using biotinylated antirabbit (Invitrogen, Carlsbad, California), antimouse (Millipore, St Charles, Missouri), or antigoat (DAKO, Carpinteria, California) secondary antibodies. Signal was amplified with Vectastain Elite ABC kit (Vector Laboratories, Burlingame, California) and color developed using 3,3-diaminobenzidine tetrahydrochloride (DAKO). For each antibody, all slides were developed for the same length of time to reveal qualitative differences in signal between treatment groups. Sections were counterstained with Harris hematoxylin and then dehydrated in an ethanol series and mounted under DPX (BDH Laboratories, Poole, United Kingdom). Secondary antibodies for immunofluorescence were antirabbit-AlexaFluor546 and antimouse-AlexaFluor488 (Invitrogen), with DNA visualized by 4Ј,6-diamidino-2-phenylindole (Invitrogen). Slides were mounted with Mowiol (Sigma). Images were captured in the one session under identical light intensity and exposure conditions. Immunodetection was performed on at least 2 sections Ͼ200 m apart. For every experiment, assessment of nonspecific binding of secondary and tertiary reagents consisted of identical treatments with primary antibody omitted.
Terminal uridine nick-end labeling
Terminal uridine nick-end labeling (TUNEL) assays were performed on Bouin's fixed testis sections using the Apoptag fluorescein direct in situ apoptosis detection kit (Millipore) according to manufacturer's instructions. Negative control to assess nonspecific binding of reagents consisted of identical treatment with enzyme omitted. Positive controls were adult mouse testis and deoxyribonuclease (DNase)-treated adult mouse testis, in which rehydrated tissue was incubated for 10 minutes with 10 U DNase (Promega Corp, Madison, Wisconsin) before incubation with terminal deoxynucleotidyl transferase.
Western blot
Cell lysate preparation and Western blots were performed as described (38) using antibodies to AMH (200 ng/mL), Cx43 (1:1000 dilution), SOX9 (200 ng/mL), ␣-tubulin (100 ng/mL; Santa Cruz), and cleaved caspase 3 (1:1000). To detect cleaved caspase 3, 1 adult mouse testis was decapsulated and halved. One piece was incubated at 42°C for 15 minutes in phenol-free DMEM (Life Technologies Inc, Rockville, Maryland) and the other half incubated at 23°C. Both halves were transferred at 37°C for 6 hours, and then tissue lysis and Western blot followed. Bound primary antibodies were detected using goat antirabbit or rabbit antigoat Alexa Fluor 680 antibodies (Invitrogen) or goat antimouse IR-800 antibody (Rockland, Gilbertsville, Pennsylvania) and visualized with the Li-Cor Odyssey (John Morris Scientific, Melbourne, Australia). Negative controls were performed for every experiment using identical samples without primary antibody to assess nonspecific binding of secondary antibody. PCNA and inhibin ␣-subunit antibodies were validated previously (36, 39) .
Imaging and morphometric analysis
Morphometric analysis of sections in which SOX9 was detected was performed using the DotSlide microscope (BX51; Olympus, Mt Waverly, Victoria, Australia) and software (Olympus Soft Imaging Solutions, Munster, Germany). The proportion of round seminiferous epithelium cross-sections with a lumen, position of Sertoli cell nuclei, and the most mature germ cell present (identified by nuclear morphology and position within the seminiferous epithelium) (40) were determined.
Testis sections used to detect GCNA, inhibin ␣-subunit, AMH, and Cx43 and adult hematoxylin-stained testes were imaged using a Provis microscope (AX70; Olympus) and AnalySIS LS Professional software (Olympus Soft Imaging Solutions). To determine the number of sections and cords/tubules required to generate a value representative of the whole testis, 90 tubules were counted in 2 sections Ͼ200 m apart in testes from 8 an-imals. Sections were digitally divided into quarters, and an approximately equal number of randomly selected round cord/ tubules cross-sections were counted per quarter. Progressive analysis of 15, 30, 45, 60, 75 , and 90 tubules determined that data were consistent when at least 60 cords/tubules were counted relating to Sertoli cell parameters and at least 35 cords/tubules for assessment of germ cell maturation.
Quantitative RT-PCR
RNA preparation, DNase treatment, cDNA synthesis, and quantitative RT-PCR were performed exactly as described previously (39) .
Statistical analysis
Linear mixed-model fit with REML (restricted maximum likelihood) was performed using the R language (41) with the specific package lme4 (42) to model DBP dose effects on testis weight with covariates of body weight and litter size and with litter number as a random effect to account for litter-to-litter variation, where y ϭ ␤ 0 ϩ ␤ 1 x 1 ϩ ␣ ϩ ␤ 3 x 3 ϩ A ϩ ⑀ (y ϭ testis weight, ␤ 0 ϭ intercept, x 1 ϭ body weight, ␣ ϭ dose as a fixed effect, x 3 ϭ litter size, A ϭ litter number, and ⑀ ϭ residual error). Because the effect of DBP on testis weight was greater than litterto-litter variation and variation due to litter size, subsequent investigations used animals selected randomly from 3 to 5 litters, with results analyzed using either Student's t test, one-way ANOVA, and Dunnet's post test or Kruskall-Wallis test and Dunn's post test, using GraphPad Prism version 5 (GraphPad Software Inc, San Diego, California). Data are presented as individual values with mean and SEM indicated by bars. Values are considered significantly different if P Ͻ .05.
Results
DBP dose-dependently impairs prepubertal mouse testis growth
DBP can cause hepatomegaly in adult rodents (43, 44) , so to assess the potential for systemic effects of orally administered DBP in prepubertal male mice, body weight and weight of selected organs were measured in day 7 and 14 mice (after 3 and 10 days of treatment, respectively). Growth of pups receiving 500 mg DBP/kg/d was reduced during the first 24 hours, with an increase in body weight of only 5% compared with a gain of 16% to 21.5% in other treatment groups (data not shown). Subsequent weight gain by of all but 2 pups in the 500 mg DBP/kg/d group was equivalent to that of all other males, and by 7 or 14 days of age, there was no difference in body weight between treatment groups. The 2 exceptional males in the 500 mg DBP/kg/d group failed to gain weight after 24 hours and were killed before completion of the experiment. Litter size has previously been reported to impact upon growth and reproductive parameters of postpubertal male mice (45) and pubertal rats (46) ; hence, litter size as well as litter-to-litter variation were considered when analyzing organ to body weights. After 3 days of treatment, a trend toward increased heart to body weight ratios with increasing DBP dose reached significance in the 500 mg DBP/kg/d group (Supplemental Table 1 ), an effect that was lost by 14 days.
After 72 hours of treatment, testis to body weight ratio in mice administered 500 mg DBP/kg/d was ϳ75% that of corn oil-fed animals ( Figure 1 , A and B). After 10 days, a dose-dependent effect was evident, with significant retardation of testis growth in mice administered 50 mg DBP/ kg/d or greater ( Figure 1 , C and D). This was estimated to result in a reduction of testis weight of 1.10, 1.52, 2.69, and 3.50 mg for animals fed 50, 100, 250, and 500 mg DBP/kg/d, respectively (Supplemental Table 2 ). Gross morphology of the testes was normal ( Figure 1E ). To gain an understanding of the consequences of DBP exposure on prepubertal testis growth and development, we undertook morphometric and immunohistochemical analysis using fixed testis sections. Because the dose-dependent effect of DBP on testis to body weight ratio was sustained after accounting for litter-to-litter variation and litter size, subsequent investigations were performed using testes from 3 to 6 animals representing 3 litters that had received DBP for 3 days (day 7 mice) and 6 to 9 animals from 4 to 5 litters after 10 days of DBP exposure (day 14 mice).
To assess whether the smaller testes in DBP-treated animals resulted from reduced proliferation or increased apoptosis, fixed testis sections were used to visualize proliferating cells by the presence of PCNA (47) and apoptotic cells using an antibody to cleaved caspase 3 (48, 49) and by TUNEL (50) . Double immunofluorescence to detect proliferating Sertoli cells (PCNA/SOX9 double-positive; Figure 1 , F-I) identified that the proliferative index of Sertoli cells in animals treated with 500 mg DBP/kg/d was half of that measured in animals administered corn oil only (P Ͻ .01). Importantly, serum concentration of FSH, a potent mitogen to immature Sertoli cells (51, 52) , was not different between treatment groups ( Figure 1J ), indicating DBP impaired testis growth in an FSH-independent manner. Cleaved caspase 3-positive cells were detected in testes of 7 dpp corn oil-treated animals, and no obvious difference was noted between treatments ( Figure 2 , A-E). This was unexpected, because the related mono-(2-ethylhexyl) phthalate increases apoptosis in mouse and human fetal testes (53), so we validated our findings by TUNEL using testis sections from 7 dpp animals treated with corn oil or 500 mg DBP/kg/d. No difference between treatments was observed ( Figure 2 , H-J), indicating apoptosis is not a significant consequence of prepubertal DBP exposure.
DBP impairs Sertoli cell maturation
During Sertoli cell maturation, the nucleus relocates from the center to the base of the cell (54) . Immunohistochemical detection of the transcription factor SOX9, a robust marker of Sertoli cell nuclei (55, 56) , identified basal localization of Sertoli cell nuclei in seminiferous cords/tubules from corn oil-treated mice ( Figure 3A ) and mice administered 1 or 10 mg DBP/kg/d, with centrally positioned Sertoli cell nuclei evident in approximately 12% of cords/tubules ( Figure 3 , B and C). Mice fed 100 or 500 mg DBP/kg/d had substantial Sertoli cell disorganization in ϳ23% of cords/tubules, including occurrence of centrally located Sertoli cell clusters (Figure 3 , D, E, and H). A second feature of Sertoli cell maturation is the development of apical-basal polarity and apical fluid secretion, which drives formation of a fluid-filled lumen, marking the transition of the seminiferous cord into seminiferous tubule (57) . Testes from mice treated with 500 mg DBP/kg/d had a significantly lower tubule to cord ratio (ϳ16%) compared with other groups (which ranged from 41%-52%), indicative of delay and/or disturbance in Sertoli cell polarization ( Figure 3I ).
To further investigate the DBP effects on Sertoli cell development, the presence and localization of AMH and Cx43 proteins were assessed. Immunohistochemical staining intensity after detection of AMH, a product of immature Sertoli cells (58, 59) , was substantially greater in mice treated with 100 and 500 mg DBP/kg/d compared with mice treated with lower doses or corn oil only ( Figure  4 , A-E). Cx43, a gap junction protein distributed throughout the cytoplasm of immature Sertoli cells but which becomes restricted to the blood-testis barrier during maturation (60) , was localized to the developing blood-testis barrier in testes of mice treated with corn oil and 1 mg DBP/kg/d. This contrasted with the localization in testes from the 10, 100, and 500 mg DBP/kg/d groups, in which strong signal was evident both within the cytoplasm and extensively along the plasma membranes between adjacent Sertoli cells (Figure 4 , H-L). 
DBP delays the first wave of spermatogenesis
To assess whether DBP affected the first wave of spermatogenesis, germ cell presence was determined by immunohistochemical detection of GCNA at day 14 (data not shown), and germ cell differentiation was assessed in hematoxylin-stained sections by characterization of germ cell nuclear morphology and cellular position within the seminiferous epithelium ( Figure 5 ). The frequency of Sertoli cell-only tubules was similar between treatment groups. Delayed spermatogenesis was observed after a dose as low as 10 mg DBP/kg/d, evident by fewer cord/tubule crosssections containing late pachytene spermatocytes. Exposure to 500 mg DBP/kg/d was the most detrimental, with an accumulation of cord crosssections containing spermatogonia and fewer sections containing meiotic cells. It is not clear whether this delay in spermatogenesis is due to impaired Sertoli cell maturation or, alternatively, whether the absence of meiotic germ cells has had an impact upon Sertoli cell biology.
DBP alters the prepubertal endocrine profile
Having determined that DBP impairs prepubertal Sertoli cell development and the first wave of spermatogenesis, we assessed whether this might arise from altered functionality of the hypothalamic-pituitary-gonadal axis. No difference in serum FSH levels was measured in 14 dpp mice treated with 100, 250, or 500 mg DBP/kg/d ( Figure 6A) ; however, circulating inhibin ␣-subunit was increased by 20% in mice treated with the highest DBP dose ( Figure 6B ). Because mice administered as little as 10 mg DBP/kg/d had smaller testes, the representation of serum total inhibin relative to testis size suggests DBP increased testicular inhibin production ( Figure 6C ). Compared with corn oil-fed animals, serum testosterone concentration (data not shown) and serum testosterone relative to body weight in 14-day-old mice were significantly lower in the 500 mg DBP/kg/d group only ( Figure 7A ). Physiological evidence of altered androgen activity was assessed by measuring AGD, an established biomarker of androgen action (61) . At 14 dpp, the AGD of mice administered 50, 100, and 500 mg DBP/kg/d was shorter compared with corn oil-treated animals ( Figure  7B ), but AGD relative to body weight was smaller in mice treated with 500 mg DBP/kg/d only ( Figure  7C ). Body weight is typically used as a normalizer to AGD in rodent studies; however, this means that AGD relative to weight ratios will change if animals gain or lose weight. We therefore used the stable feature of trunk length (from foreleg to base of tail), which does not differ between treatment groups, to normalize AGD ( Figure 7D ) and found that AGD to trunk length ratio was smaller in all DBP-treated groups compared with corn oil-fed males ( Figure 7E ). These data demonstrate that androgen production and/or action were affected in all treatment groups at some stage during the 10-day exposure period, with the most severe effects observed in animals exposed to 500 mg DBP/ kg/d, in which AGD and AGD relative to trunk length were equivalent to those measured in females.
Molecular evidence of altered testosterone production was investigated indirectly because we did not have sufficient tissue to measure testicular testosterone. AR protein was readily detected in the nuclei of Sertoli, peritubular myoid, and Leydig cells in testes from 14 dpp animals receiving corn oil or 500 mg DBP/ kg/d (Figure 7F ), suggesting DBP does not affect AR protein expression or cause its mislocalization. Quantitative RT-PCR measurement identified similar mRNA levels of AR transcript in testes from corn oil-fed animals, and animals that received 500 mg DBP/ kg/d, consistent with the lack of an obvious difference in AR protein between these 2 groups ( Figure 7G ). Tran- script levels of the Sertoli cell-specific transcript Wilms tumor homolog 1 (WT1) was not different between groups. When normalized to WT1, fewer transcripts of the Sertoli cellspecific androgen target genes Rhox5 and Spinlw1 were present in DBP-treated testes; however, these testes contained significantly more transcripts encoding AMH, a gene considered to be downregulated by androgens (62) (Figure 7G ). Testicular cells in DBP-treated animals therefore have the capacity to respond to androgens, but that testicular environment appears to be one of insufficient androgen availability.
Evidence of adult effects after prepubertal DBP exposure
Having identified marked dosedependent effects of prepubertal DBP exposure on Sertoli and germ cell development and endocrine changes, we undertook a pilot study to delineate adult consequences of prepubertal DBP exposure. Mice were administered corn oil or DBP (1, 10, 100, or 500 mg/kg/d) from 4 to 21 days of age then were maintained without treatment until 8 weeks. Testis to body weight ratios were significantly smaller at 500 mg DBP/kg/d only ( Figure 8A ). There was no difference in epididymis weight, although weights were variable in animals treated with 500 mg DBP/kg/d ( Figure 8B ). AGD was significantly smaller in all DBP-treated adult mice ( Figure 8C ). Body weight did not differ between groups, although animals in the 10 or 100 mg DBP/kg/d group trended toward being lighter. AGD to body weight ratios were smaller in mice fed 1 or 500 mg DBP/kg/d ( Figure 8D ). Trunk length was not different between groups ( Figure 8E ), and when plotted relative to trunk length, AGD was shorter in all DBP-treated animals ( Figure 8F ). These data indicate that DBP exposure restricted to the prepubertal period suppresses androgen action, the effects of which persist into adulthood. Histological analysis of hematoxylin-stained testis sections identified unusual germ cell loss in testes from DPBtreated animals ( Figure 8G ). Although full spermatogenesis was evident in testes of all animals, each mouse also had several tubules in which germ cells were missing. Categorization of these abnormalities according to the absence of mitotic/premeiotic germ cells (Figure 8Gi) , postmeiotic germ cells (Figure 8Gii ), or disruption of spermatogenesis in only part of the tubule ( Figure 8G , iii and iv) identified multiple classes of lesions in all DBP-treated animals. Abnormalities were noted in testes of 2 corn oilfed animals, but only one class of defect was detected in each of these animals. This qualitative assessment illustrates the possibility of long-term impacts of prepubertal DBP exposure on adult mice. Epididymal histology was overtly normal in all DBP-treated animals and all epididymides contained sperm. Fertility testing was beyond the scope of this study, but is a focus of future investigations.
Discussion
This study conclusively demonstrates that the neonatal and prepubertal murine testis is highly susceptible to DBP-induced damage. We found effects on testis growth, Sertoli cell maturation, and germ cell differentiation at doses 50-to 500-fold lower than those typically used to produce effects in rats.
Species-specific effects of phthalates on the testis have been a challenge to researchers who seek to understand whether, and how, phthalates affect testis development and fertility. Investigations using the rat have identified that phthalates impair fetal testosterone production and suppress the expression of steroidogenic enzymes, leading to physiological features indicative of impaired androgen action. The inability to reproduce these antiandrogenic effects in the fetal mouse or in fetal human testis explants has made links between phthalate exposure and testicular dysgenesis difficult to test. Our findings that phthalate exposure during early postnatal mouse development lowers circulating testosterone and suppresses molecular and physiological outcomes of androgen action confirm that DBP does have antiandrogenic activity in the mouse, establishing that the age at which phthalate exposure is assessed is an important consideration for understanding effects on the testis. Furthermore, our evidence that prepubertal DBP exposure is associated with reduced AGD in adult mice presages the potential for detrimental outcomes to arise after prepubertal exposure to much lower doses of DBP than previously considered.
Most published research has focused on phthalate exposure during gestation, because conditions associated with testicular dysgenesis syndrome are considered to initiate from aberrancies in human fetal development. In the rat, fetal Sertoli cells and germ cells are phthalate targets (31, 63). We have not only confirmed that DBP targets . DBP increases inhibin ␣-subunit production but does not alter serum FSH levels in 14-day-old mice. A, Serum FSH concentrations were not different between mice fed DBP or corn oil for 10 days. In the first assay (left graph), only 4 animals in the 500 mg DBP/kg/d group were analyzed. The variability between these samples made it difficult to determine whether circulating FSH was different in these animals or not, so the assay was repeated with serum from different animals fed either corn oil or 500 mg DBP/kg/d (right graph). Although the concentrations measured in this second group of animals were lower than in the first assay, all quality control parameters were identical. Therefore, the difference in values obtained between the 2 assays was due to differences in serum FSH concentrations in the independent animal groups, not technical issues associated with the RIA. B, Circulating inhibin was elevated in mice fed 500 mg DBP/kg/d. C, Plotted relative to testis size, testicular inhibin production is higher in animals fed 250 or 500 mg DBP/kg/d. Differences between groups were tested for significance by Kruskal Wallis test and Dunn's posttest (A [left graph], B, and C) or Student's t test (A, right graph), with P Ͻ .05 considered significant. Each data point represents a value obtained from a different animal, with bars indicating mean Ϯ SEM. Different letters indicate significant differences between groups, and the number of animals per treatment group are indicated below the graphs. D-H, Immunohistochemical detection of the inhibin ␣-subunit in testis sections from these mice show increased staining for the inhibin ␣-subunit in DBP-treated animals. Images are representative of n ϭ 6 animals per group. Sections are counterstained with Harris hematoxylin (blue) to visualize nuclei. I and J, No signal is seen within the seminiferous epithelium in the absence of primary antibody (I) or in sections from inhibin ␣-subunit knockout null (Inha Ϫ/Ϫ ) animals incubated with primary antibody (J); staining within the interstitium is due to reactivity between the antimouse secondary antibody and endogenous mouse immunoglobulins. Scale bar, 100 m.
these same cell types in the prepubertal mouse testis but have also demonstrated that the neonatal-prepubertal testis is acutely vulnerable to DBP. Prepuberty is a critical time during which the foundations of adult fertility are being established, and damage to testicular cells, or indeed the hypothalamic-pituitary-gonadal axis, has the potential to have an impact on adult fertility as indicated by our pilot data from adult mice.
A prediction arising from this study is that greater AMH production in DBP-exposed animals will also affect (5) (9) (6) (10) (9) (7) (8) (9) (5) (9) (6) (10) (9) (7) corn oil DBP500 control (9) (5) (9) (6) (10) (9) (7) (8) (9) (5) (9) (6) (10) (9) (7) Evidence of effects in adulthood after prepubertal DBP exposure. A, Testis to body weight ratio was lower in mice that were administered 500 mg DBP/kg/d from 4 to 21 days of age (n ϭ 9 -10 per group). B, Epididymis to body weight ratio did not differ between groups, although there was marked variation of weights in animals treated with 500 mg DBP/kg/d. C, Mice exposed prepubertally to DBP had a smaller AGD compared with animals that were fed corn oil. D, When plotted relative to body weight, AGD was lower in mice treated with 1 or 500 mg DBP/kg/d. E and F, Trunk length did not differ between treatment groups (E), and when AGD was represented relative to trunk length (F), values in DBP-exposed mice were lower in all treatment groups compared with corn oil-fed animals. G, Defective spermatogenesis was observed in some tubules of animals that were fed DBP before puberty (indicated by asterisks), although all animals also had tubules containing normal spermatogenesis. Defects included absence of premeiotic/meiotic germ cells (i), loss of postmeiotic germ cells (ii), or both (iii) and only partial tubule degeneration (iv). Histological assessment of 6 animals per DBP treatment group and 5 corn oil-fed animals identified that all DBP-treated animals had multiple defects (shaded boxes indicate type of defect observed). Two of the animals that were treated with corn oil also displayed sporadic defects, but not the combination of effects that were observed in the DBP-treated animals. Leydig cells. Downregulation of AMH synthesis within the first few weeks after birth is important for Leydig cell proliferation and differentiation (64) and emergence of the adult Leydig cell population (65) . In vitro, AMH blocks testosterone production by adult Leydig cells (66) , and in AMH-overexpressing mice, LH receptor expression is reduced and adult Leydig cells fail to develop (67) . Because androgens are essential for the transition from progenitor to mature adult Leydig cell (68) , the sustained production of AMH that we observe in DBP-treated animals may affect development and maturation of adult Leydig cells, alter their eventual number, or impair their steroidogenic capacity.
What is also of great importance, but which has not been well investigated to date, is the impact that phthalate exposure has on male general health and well-being. Androgens have important peripheral actions in supporting the development and homeostasis of other organs, including muscle, bone, and brain (69 -71) . Our finding of reduced circulating testosterone in animals exposed prepubertally to DBP demonstrates that phthalates can impair the endocrine function of the testis. This new evidence of impaired androgen action, which remains apparent in adulthood, reveals the potential for prepubertal phthalate exposure to have broad and long-term health impacts, identifying a knowledge gap that requires urgent attention.
Our data also shed new light on the molecular mechanisms of phthalate action. The general consensus from experimental studies and epidemiological data suggest that phthalates are antiandrogenic; however, no direct interaction between phthalates and the AR have been demonstrated (72) , and as such, the mechanisms by which phthalates act is not fully understood. Our molecular, endocrine, and phenotypic analyses suggest DBP causes suppression of activin signaling through upregulation of its potent inhibitor, inhibin. Activin A is a ligand of the TGF-␤ superfamily that promotes Sertoli cell proliferation (51, 52, 73) , is required for normal Sertoli cell maturation, and regulates the pace of the first wave of spermatogenesis (73) (74) (75) , all of which are affected in this study. Activin A is also implicated in androgen production because it upregulates transcripts encoding the testosterone-synthesizing enzyme hydroxysteroid-17␤-dehydrogenase in immature Sertoli cells (73) . Considered together, these findings strongly link reduced activin activity as the intermediary between DBP and its antiandrogenic actions. Inhibin is also important as a negative feedback regulator that suppresses pituitary FSH production. Intriguingly, although we measured elevated serum inhibin in mice administered 500 mg DBP/kg/d, this was not reflected in altered serum FSH, suggesting that the normal endocrine communication between the pituitary and the testis was disrupted.
Our findings are particularly relevant to understanding phthalate effects during infancy and childhood. Typical daily phthalate intake in humans is estimated to be in the microgram range, with exposure in children around 2-to 4-fold higher than adults (76) ; however, the use of phthalates in medications and medical devices means that individuals with long-term medical conditions have much greater exposure than the general population. Exposure of infants in intensive care is estimated at 20 mg phthalate per day (25, 77, 78) , whereas enteric coatings contain between 1 and 16 mg phthalate per tablet or capsule (79) . Increased concentrations of urinary metabolites in children and adults taking these medications reflect this high exposure (20 -22, 76) . Our findings that doses as low as 10 mg DBP/kg/d impact prepubertal mouse testis development, and that prepubertal exposure to 1 mg DBP/kg/d results in an adult phenotype of impaired androgen action, raise concerns that human exposure from medical interventions may indeed be harmful. One of the challenges researchers and clinicians face is how to identify children at risk. Our discovery that DBP exposure correlates with an altered FSH to inhibin ratio and reduced circulating testosterone provides an opportunity to apply endocrine profiling as a diagnostic tool.
In conclusion, the prepubertal mouse testis is highly susceptible to DBP, with dose-dependent effects on somatic and germ cell populations observed at 50-to 500-fold lower doses than presently understood. The potential for DBP to induce long-term negative effects on the testis in terms of fertility and its role as an endocrine organ necessitates urgent investigation. Our model of mouse phthalate exposure provides a valuable tool for investigating phthalates in human male reproductive disorders, pubertal timing, fertility, and endocrine function and in dissecting the pathways involved in phthalate sensitivity and resistance.
